Prosecution Insights
Last updated: August 18, 2026

Examiner: DUTT, ADITI

Tech Center 1600 • Art Units: 1600 1649 1675

This examiner grants 47% of resolved cases

Performance Statistics

47.1%
Allow Rate
-12.9% vs TC avg
407
Total Applications
+48.2%
Interview Lift
1466
Avg Prosecution Days
Based on 382 resolved cases, 2023–2026

Rejection Statute Breakdown

4.7%
§101 Eligibility
12.2%
§102 Novelty
34.4%
§103 Obviousness
28.7%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17809376 EXPRESSION OF NEUROPEPTIDES Non-Final OA California Institute of Technology
15893456 USE OF GUT MICROBIOTA IN THE DIAGNOSIS AND THERAPEUTICS OF PARKINSON'S DISEASE Non-Final OA CALIFORNIA INSTITUTE OF TECHNOLOGY
17925235 BIOMARKER FOR DIAGNOSIS OF DEMENTIA Non-Final OA TOHOKU UNIVERSITY
16379763 IMMORTALIZATION OF CELLS INCLUDING NEURONAL CELLS Non-Final OA The Johns Hopkins University
17111820 PEPTIDIC LINKER WITH REDUCED POST-TRANSLATIONAL MODIFICATION Non-Final OA Hoffmann-La Roche Inc.
17973020 Simplified Compositions and Methods for Generating Neural Stem Cells from Human Pluripotent Stem Cells Non-Final OA Wisconsin Alumni Research Foundation

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month